Skip to main content
SpringerLink
Log in

Can the adjusted mean SLEDAI-2K predict organ damage and coronary artery disease?

  • Practice Point
  • Published:

From Nature Clinical Practice Rheumatology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research Guidance for Industry (online March 2005) Draft Guidance: Guidance for Industry. Systemic Lupus Erythematosus—Developing Drugs for Treatment [http://www.fda.gov/cder/guidance/6496dft.htm] (accessed March 2005)

  2. The American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria (2004) The American College of Rheumatology response criteria for Systemic Lupus Erythematosus clinical trials: measures of overall disease activity. Arthritis Rheum 50: 3418–3426

  3. Liang MH Translating outcomes measurement in experimental therapeutics of systemic rheumatic disease to patient care. Clinics in Rheumatic Disease, in press

  4. Tufte ER (2001) The Visual Display of Quantitative Information, edn 2. Cheshire: Graphics Press

    Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Medicine at the Harvard Medical School, Boston, MA, USA

    Matthew H Liang

Authors
  1. Matthew H Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew H Liang.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liang, M. Can the adjusted mean SLEDAI-2K predict organ damage and coronary artery disease?. Nat Rev Rheumatol 2, 10–11 (2006). https://doi.org/10.1038/ncprheum0071

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0071

  • Springer Nature Limited

Search

Navigation